Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Accelerated Stability Testing of Cream Formulations – V 2.0

Posted on By

Creams: SOP for Accelerated Stability Testing of Cream Formulations – V 2.0

Standard Operating Procedure for Accelerated Stability Testing of Cream Formulations

Department Creams
SOP No. SOP/CRM/131/2025
Supersedes SOP/CRM/131/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to outline the procedure for conducting accelerated stability testing of cream formulations. Accelerated stability testing helps predict the shelf life and stability of cream products by subjecting them to controlled conditions of temperature and humidity. This process is essential for ensuring product efficacy and safety throughout its intended shelf life.

2. Scope

This SOP applies to all cream formulations produced at the facility. It includes the procedure for conducting accelerated stability tests under elevated temperature and humidity conditions to simulate long-term storage conditions in a shorter period.

3. Responsibilities

  • Production Team: Responsible for providing representative samples of the cream formulations for stability testing and ensuring the samples are appropriately labeled and stored.
  • Quality Control (QC) Team: Responsible for conducting accelerated stability testing, monitoring storage conditions, and recording test results. The team also ensures that the samples are analyzed at specified time intervals.
  • Quality Assurance (QA) Team: Responsible for reviewing the stability test
results, verifying compliance with specifications, and approving the release of stability data for regulatory submission or product release.

4. Accountability

The QC Manager is accountable for ensuring that accelerated stability testing is carried out as per this SOP. The Production Supervisor is responsible for ensuring that samples are properly collected and labeled. The QA Manager ensures the integrity and compliance of stability testing with regulatory requirements.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that all necessary equipment for accelerated stability testing is available, including temperature-controlled stability chambers, humidity control units, and sample containers.
  2. Ensure that the stability chambers are calibrated and operating at the desired temperature (e.g., 40°C) and humidity (e.g., 75%) before testing.
  3. Review the formulation batch records to determine which cream formulations are ready for stability testing and to identify the number of samples required.

5.2 Sample Collection

  1. Collect representative samples of the cream formulation to be tested. The sample size should be sufficient to perform tests at various time intervals.
  2. Label each sample with relevant information, including the batch number, sampling date, and the purpose of the test (e.g., accelerated stability testing).
  3. Ensure that the sample containers are sealed properly to prevent contamination or leakage during storage.

5.3 Accelerated Stability Testing Procedure

  1. Place the labeled samples in the stability chamber set at the predefined temperature and humidity conditions (e.g., 40°C and 75% RH) to simulate accelerated aging conditions.
  2. Monitor the temperature and humidity levels inside the chamber to ensure they remain within the specified range throughout the testing period.
  3. Analyze the samples at designated time intervals, typically at 1, 2, 3, and 6 months. At each interval, test for the following attributes:
    • Physical Appearance: Inspect for changes in color, consistency, or phase separation.
    • Viscosity: Measure the viscosity using a viscometer to ensure it remains within specification.
    • pH Level: Measure the pH using a pH meter to ensure the formulation remains within the desired pH range.
    • Microbial Testing: Conduct microbial limit testing to ensure the cream remains free from microbial contamination.
    • Odor and Texture: Check for any off-odor or texture changes that may indicate instability.
  4. Document all observations and test results, including any deviations or unexpected changes, in the Accelerated Stability Testing Log (Annexure-1).

5.4 Interpretation of Results

  1. Compare the test results at each time interval with the baseline data from the initial test (e.g., viscosity, pH, physical appearance).
  2. If any of the product characteristics fall outside the established limits (e.g., significant color change, viscosity decrease, pH shift), mark the test as “Fail” in the Accelerated Stability Testing Log (Annexure-1).
  3. If the product remains stable according to all specified criteria, mark the test as “Pass” and proceed with further testing or packaging if required.
  4. If failures occur, initiate an investigation into the cause of the instability. This may include reviewing raw material specifications, manufacturing processes, or storage conditions.

5.5 Post-Test Activities

  1. Record the test results, including batch number, sample ID, time intervals, and all relevant observations, in the Accelerated Stability Testing Log (Annexure-1).
  2. Review all data and investigate any deviations from expected results. If necessary, implement corrective actions or adjustments to the formulation and re-test the samples.
  3. Submit the stability test results for approval by the QA team before proceeding with any product release or further production activities.

5.6 Documentation and Record-Keeping

  1. Ensure that all stability testing records are complete, accurate, and securely stored. This includes the Accelerated Stability Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Accelerated Stability Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for Stability Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Accelerated Stability Testing Log

Batch Number Sample ID Sampling Date Temperature (°C) Humidity (%) Viscosity (cP) pH Physical Appearance Operator
12345 S-001 21/01/2026 40°C 75% 500 cP 5.5 No visible changes John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Viscosity decreased beyond acceptable limit Reviewed formulation, adjusted ingredient ratio Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Documentation of Machine Operations in Cream Production - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: BA-BE Studies: SOP for Emergency Exit and Fire Drill Plan at Clinical Site – V 2.0
Next Post: Elixir Department: SOP for Use of Barcode Systems During Dispensing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version